BioNexus KC

What BioNexus KC does

BioNexus KC is a 501(c)(3) nonprofit regional convener headquartered in Kansas City, Missouri (30 West Pershing Road, Suite 210), founded in 2001 as the Kansas City Area Life Sciences Institute (KCALSI) and rebranded under its current name in March 2018. The organization coordinates life sciences research and commercialization activity across the Kansas City bi-state region, operating a portfolio of interconnected programs: the Research Development Grants Program (165+ grants, $10M+ awarded across 2002–2024 with NIH-modeled peer review and a documented $13.10 regional ROI per $1 invested), Collaborate2Cure Research Grants, the Blue KC Outcomes Research Grants (a partnership with Blue Cross and Blue Shield of Kansas City covering autism, asthma, sepsis, cardiovascular and maternal/fetal health), the Patton Trust Research Development Grants (focused on pediatric disease genetics), the Science2Art public engagement program (donating $180,000+ to regional STEAM programs since 2014), and Customized Research Grants administration offered to partner organizations. Wholly-owned subsidiary programs include Digital Health KC (launched May 2023, a community-wide digital health innovation initiative led by a former Cerner Health Services president) and KC BioHub (a biomanufacturing and biologics program that received the U.S. Department of Commerce National Tech Hub designation in October 2023). BioNexus KC formally partnered with RareKC in June 2026 to address the approximately 250,000 Kansas City residents affected by rare diseases, adding a patient engagement layer to a previously researcher-facing portfolio.

The organization operates through a community-led go-to-market model rather than product sales, funded by tax-deductible donations from individuals, corporations, and foundations; tiered event sponsorships (Gold/Silver/Bronze for an annual dinner attracting 500+ regional leaders); customized grant administration fees; and competitive federal and philanthropic grants. The customer base is institutional and segmented: ten founding/governing stakeholder institutions (Children's Mercy Kansas City, Saint Luke's Health System, University of Kansas, University of Kansas Medical Center, University of Missouri, University of Missouri-Kansas City, Kansas State University, Kansas City University, University Health, University of Central Missouri) anchor the structure; over 30 strategic partners (Kauffman Foundation, Greater Kansas City Chamber of Commerce, KC Animal Health Corridor, Frontiers CTSI, Blue Cross and Blue Shield of Kansas City) extend the network; and end beneficiaries include academic and clinical researchers (grant recipients), digital health startups, rare disease patients and families, and STEAM students. The organization is governed by a President & CEO (Dennis Ridenour, since February 2019), supported by a leadership team of approximately 10 staff including a President & Regional Innovation Officer (Melissa Roberts Chapman, leading the Tech Hub consortium), President of Digital Health KC (Dick Flanigan), VP Strategy & Partnerships, VP Operations, Scientific Director, Program Director, and Marketing Director.

Underlying technology is non-proprietary in the software sense but constitutes an institutional platform: an NIH-modeled scientific peer-review infrastructure for grant evaluation, a regional stakeholder engagement network, a recurring annual event and conference series (Annual Event, Digital Health Day, Collaborate2Cure, Science2Art exhibitions, Nexus Informatics Conference), and content channels including a 5,000+ subscriber newsletter and Expert Exchange video series. BioNexus KC is a private nonprofit organization with no parent company and no equity investors; operating geographies are limited to the Kansas City region (Missouri and Kansas).

Name

BioNexus KC

Legal name

BioNexus KC

Website

https://bionexuskc.org

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

BioNexus KC is a 501(c)(3) nonprofit regional convener that coordinates life sciences research, digital health innovation, and biomanufacturing activity across the Kansas City region, serving academic researchers, healthcare systems, startups, rare disease patients, and STEAM students through grant programs, ecosystem initiatives, and events.

Ownership category

akta.pro rank

Product category

Life Sciences Ecosystem Coordination

NAICS

Grantmaking and Giving Services (81321), Scientific Research and Development Services (5417)

akta.pro primary industry

Science, Technology & Innovation Administration (National R&D Policy) (BPAIAAAK)

Keywords

• Life sciences coordination
• Research grant administration
• Regional ecosystem development
• Biomedical research funding
• Healthcare innovation partnerships

Headquarters

HQ city

Kansas City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Donations and Charitable Contributions: Tax-deductible donations from individuals, corporations, and foundations supporting STEAM education and life sciences advancement in the Kansas City region
2. Event Sponsorships: Sponsorship revenue from annual events, with Gold, Silver, and Bronze tiers; annual event attracts over 500 regional leaders
3. Customized Grants Administration: Fee-based administration of grant programs for partner organizations, including scientific review process facilitation and project monitoring

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

BioNexus KC is a 501(c)(3) nonprofit that serves as the regional convener for life sciences research and innovation in the Kansas City area. The organization administers research grant programs (over $10 million across 165+ grants since 2002), operates Digital Health KC and KC BioHub programs, partners with RareKC, and runs Science2Art STEAM initiatives to advance collaboration across industry, academia, and healthcare.

Product overview

BioNexus KC is a 501(c)(3) nonprofit organization serving as a regional convener and catalyst for life sciences innovation in the Kansas City region. The organization operates a portfolio of interconnected programs including Digital Health KC, KC BioHub, Science2Art, Collaborate2Cure Research Grants, and the broader Research Development Grants Program (which includes Blue KC Outcomes Research Grants and Patton Trust Research Development Grants). Additional offerings include Expert Exchange video content and Customized Research Grants Program services. BioNexus KC houses Digital Health KC and KC BioHub, partners with RareKC, and brings together leaders from industry, academia, and healthcare to drive progress at the nexus of human and animal health, healthcare and information technology, and academia and industry. The organization facilitates grant funding (awarding over $10 million across 165 grants from 2002-2024), educational programs, events (including an Annual Event attracting 500+ regional leaders), and community initiatives to strengthen the regional life sciences ecosystem.

Differentiator

Problem solved

Functional benefit

Brands

• Digital Health KC: A community-wide initiative to accelerate the Kansas City region's position as a global hub for digital health innovation and collaboration
• KC BioHub
• Science2Art
• Science to Art
• Collaborate2Cure
• RareKC

Products and services

• Digital Health KC A program housed by BioNexus KC that brings together industry, academia, and healthcare leaders to solve real-world digital health challenges in the Kansas City region through events, ecosystem building, and partnership facilitation.
• KC BioHub A program housed by BioNexus KC designated as a National Tech Hub for biomanufacturing and biologics, connecting people and resources to build a stronger life sciences and biomanufacturing ecosystem across the Kansas City region.
• Science2Art A program that connects scientists with the broader community by translating complex research into engaging visual stories and exhibitions, with proceeds supporting regional STEAM education programs.
• Research Development Grants Program A competitive research grants program using NIH-modeled peer review to fund early-stage life sciences research projects in the Kansas City region, with awards up to $50,000 to generate preliminary data for competitive proposals.
• Collaborate2Cure Research Grants A grants program created to stimulate regional scientific collaboration and develop innovative ways to solve scientific challenges, encouraging multidisciplinary life sciences proposals across institutions.
• Blue KC Outcomes Research Grants Health outcomes research grants funded in partnership with Blue Cross and Blue Shield of Kansas City to fund local researchers and physicians making advancements in autism, asthma, sepsis, heart disease, child/teen health, and maternal/fetal medicine.
• Patton Trust Research Development Grants Research development grants focused specifically on the genetic basis of diseases that predominantly affect children, administered by BioNexus KC without requiring inter-institutional collaborations.
• Expert Exchange A video program featuring regional researchers, innovators, and life sciences trailblazers, showcasing breakthroughs and highlighting experts driving equity and life sciences advancements.
• Customized Research Grants Program A fee-based service offering BioNexus KC's infrastructure and expertise to partner organizations to administer customized grants programs, including scientific review facilitation, project monitoring, and budget reporting.
• RareKC Partnership A formal partnership program with RareKC to expand patient engagement, strengthen support for families affected by rare genetic conditions, and connect approximately 250,000 people in Kansas City affected by rare diseases with coordinated resources.

Quantifiable outcome

• $13.10 returned to region for every $1 invested in research grants
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

17 partnerships are on record, tiered core partner, core program, stakeholder institution, partner alliance and strategic partner.

• RareKCcore partnerStrategic or Co-development Partner · 15 June 2026Formalized partnership to expand patient engagement, strengthen support for families affected by rare genetic conditions, and connect the community with coordinated resources. RareKC was founded by Kelly Ranallo in 2015 to drive innovation in rare disease diagnosis, care, and treatment.
• KC BioHubcore programOthers · 23 October 2023Part of BioNexus KC, designated as a National Tech Hub for biomanufacturing and biologics. Works to connect and strengthen the regional life sciences ecosystem.
• Digital Health KCcore programOthers · 11 May 2023A program under BioNexus KC focused on accelerating Kansas City region's position as a global hub for digital health innovation and collaboration. Includes events like Digital Health Day and EDA-funded initiatives.
• Children's Mercy Kansas Citystakeholder institutionStrategic or Co-development PartnerMajor pediatric healthcare system and founding stakeholder institution supporting BioNexus KC's life sciences mission in the Kansas City region.
• University of Kansas Medical Centerstakeholder institutionStrategic or Co-development PartnerMajor academic medical center and founding stakeholder institution providing research leadership in life sciences.
• Kansas State Universitystakeholder institutionStrategic or Co-development PartnerLand-grant university and stakeholder institution contributing animal health and research expertise to the regional ecosystem.
• University of Missouristakeholder institutionStrategic or Co-development PartnerMajor research university added as stakeholder in 2005, home to Roy Blunt NextGen Precision Health Initiative.
• Saint Luke's Health Systemstakeholder institutionStrategic or Co-development PartnerHealthcare system stakeholder supporting research initiatives including cancer research and cardiovascular outcomes research.
• University of Missouri-Kansas Citystakeholder institutionStrategic or Co-development PartnerUrban research university contributing to life sciences research and workforce development in the region.
• Global Prairiepartner allianceGTM or Marketing PartnerDigital marketing and advertising agency and member of Partner Alliance supporting BioNexus KC's marketing and communications efforts.
• Labconcopartner allianceGTM or Marketing PartnerLaboratory equipment manufacturer and Partner Alliance member providing scientific expertise and resources.
• Linda Hall Librarypartner allianceGTM or Marketing PartnerScience library and Partner Alliance member hosting Science2Art exhibitions and supporting science education initiatives.
• Kauffman Foundationstrategic partnerStrategic or Co-development PartnerMajor philanthropy organization supporting entrepreneurship and ecosystem development in Kansas City region.
• Greater Kansas City Chamber of Commercestrategic partnerStrategic or Co-development PartnerRegional chamber of commerce supporting life sciences economic development initiatives.
• Frontiers: University of Kansas Clinical and Translational Science Institutestrategic partnerStrategic or Co-development PartnerNIH-funded clinical and translational science institute advancing research collaboration across the region.
• Blue Cross and Blue Shield of Kansas Citystrategic partnerStrategic or Co-development PartnerHealth insurer partner supporting Transforming KC Research Grants focused on health outcomes research in autism, asthma, sepsis, heart disease, and maternal/fetal medicine.
• KC Animal Health Corridorstrategic partnerStrategic or Co-development PartnerRegional initiative established in 2005 identifying animal health as a regional strength, supported by BioNexus KC's predecessor KCALSI.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• BIOCOM (California Life Sciences): California-based life sciences trade association serving the San Diego and Bay Area clusters. Comparable regional convening, policy advocacy, and grant/networking role at a much larger scale, with a similar member-based non-profit structure.
• NewYorkBIO: New York-based non-profit trade association serving the state's life sciences industry. Performs the same regional advocacy, networking, and ecosystem-building functions as BioNexus KC, including grant program administration and stakeholder convening.
• BioKansas: Statewide non-profit trade association for the bioscience industry in Kansas. BioNexus KC's own CEO Dennis Ridenour previously led BioKansas, and both organizations pursue overlapping life sciences ecosystem-building missions in adjacent geographies with similar stakeholder models.
• MassBio: Massachusetts-based life sciences trade association and convener with a multi-decade operating history. MassBio represents the larger, more mature version of BioNexus KC's regional life sciences convening and policy advocacy role on the East Coast.
• BioSTL: St. Louis-based non-profit regional bioscience ecosystem builder offering BioGenerator, investment, and convening programs. Operates the same regional life sciences cluster model as BioNexus KC in a neighboring Midwestern metro with comparable grantmaking, networking, and incubator functions.

Regional players

• Indiana Biosciences Research Institute: Indianapolis-based non-profit life sciences research institute convening industry, academic, and government partners. Plays a similar convening and applied research role in Indiana with comparable industry-academic bridge funding, though focused on applied research rather than pure ecosystem orchestration.
• Cincinnati Children's Innovation Fund: Pediatric research and commercialization entity in the Cincinnati region. Operates a comparable pediatric-disease-focused research and innovation model in a nearby Midwestern geography that does not directly compete with BioNexus KC but addresses overlapping stakeholder types.

Others

• National Organization for Rare Disorders (NORD): National rare disease patient advocacy organization. BioNexus KC's RareKC partnership addresses a similar rare disease community focus as NORD does at the national level, providing a useful adjacency for comparison of patient engagement and convening approaches.
• Kauffman Foundation: Major Kansas City-based philanthropy focused on entrepreneurship. BioNexus KC lists Kauffman as a Strategic Partner; Kauffman's regional innovation agenda and grantmaking capabilities partially overlap with BioNexus KC's convening and ecosystem development mission.
• Research!America: National non-profit advocacy alliance for medical and health research. Comparable in its national-level convening and R&D advocacy role to what BioNexus KC performs at a regional level, providing thought leadership and policy advocacy for the U.S. research enterprise.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• Xx.com/bionexuskc

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioNexus KC